Glial mitogenic factors, their preparation and use
US6972280B2 · kind B2 · utility
3Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 1996 |
| Grant date | Dec 6, 2005 |
| Priority date | — |
| Expiry date | Oct 22, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for inducing myelination of neural cells by glial cells, The methods involve contacting glial cells with polypeptides comprising epidermal growth factor-like domains encoded by the GGF/p185 erb B2 ligand gene provided as a feature of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.